Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Quednow

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 9, 2022
Beyond the Brain: Behavioral Sociomics and the Future of PsychiatryBoris B Quednow
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[Problems of therapeutic service in primidone therapy]B Quednow, H Walther
Zeitschrift Fur Arztliche Fortbildung|December 1, 1980
[The determination of anticonvulsants within the framework of the therapy service]B Quednow, H Walther
Progress in Brain Research|January 30, 2016
Human pharmacology for addiction medicine: From evidence to clinical recommendationsBoris B Quednow, Marcus Herdener
Frontiers in Pharmacology|February 7, 2018
How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence HypothesesStephan Schleim, Boris B Quednow
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 8, 2025
Ketamine addiction in Europe: Any risks on the horizons?Francesco Bavato, Boris B Quednow
Neuroscience and Biobehavioral Reviews|June 12, 2022
The role of serotonin in declarative memory: A systematic review of animal and human researchRebecca Coray, Boris B Quednow
Physics of Life Reviews|October 25, 2025
What challenges remain after 25 years of the enhancement debate?: Comment on "To enhance or not to enhance: A debate about cognitive enhancement from a psychological and neuroscientific perspective" by Sandra Grinschgl, Manuel Ninaus, Guilherme Wood and Aljoscha C. NeubauerStephan Schleim, Boris B Quednow
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[Problems of therapeutic service in valproate therapy]E Köhler, B Quednow, H Walther
Brain : a Journal of Neurology|May 15, 2026
Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factorsBoris B Quednow, Rebecca C Coray
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 9, 2022
Beyond the Brain: Behavioral Sociomics and the Future of PsychiatryBoris B Quednow
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[Problems of therapeutic service in primidone therapy]B Quednow, H Walther
Zeitschrift Fur Arztliche Fortbildung|December 1, 1980
[The determination of anticonvulsants within the framework of the therapy service]B Quednow, H Walther
Progress in Brain Research|January 30, 2016
Human pharmacology for addiction medicine: From evidence to clinical recommendationsBoris B Quednow, Marcus Herdener
Frontiers in Pharmacology|February 7, 2018
How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence HypothesesStephan Schleim, Boris B Quednow
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 8, 2025
Ketamine addiction in Europe: Any risks on the horizons?Francesco Bavato, Boris B Quednow
Neuroscience and Biobehavioral Reviews|June 12, 2022
The role of serotonin in declarative memory: A systematic review of animal and human researchRebecca Coray, Boris B Quednow
Physics of Life Reviews|October 25, 2025
What challenges remain after 25 years of the enhancement debate?: Comment on "To enhance or not to enhance: A debate about cognitive enhancement from a psychological and neuroscientific perspective" by Sandra Grinschgl, Manuel Ninaus, Guilherme Wood and Aljoscha C. NeubauerStephan Schleim, Boris B Quednow
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[Problems of therapeutic service in valproate therapy]E Köhler, B Quednow, H Walther
Brain : a Journal of Neurology|May 15, 2026
Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factorsBoris B Quednow, Rebecca C Coray
Pageof 25